Irvine-based University Lab Partners said this morning that it has named the winners of its annual pitch competition. The nonprofit, wet-lab incubator said it had over 40 applications for this year's pitch competition, and named Hybrid Biot...

San Diego-based Aardvark Therapeutics announced today that it has raised $85M in a Series C funding round. The funding was led by Decheng Capital and also included Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial ...

La Jolla-based Enlaza Therapeutics, which is working on protein drugs, says it has raised $100M in a Series A financing round. The funding was led by Life Sciences Group of J.P. Morgan Private Capital, and also included existing investors F...

San Diego-based biotechnology company Endeavor BioMedicine said this morning that it has raised $132.5M in the company's Series C financing. The company said the funding was led by AyurMaya, an affiliate of Matrix Capital Management, plus n...

Rakuten medical, a company developing precision therapies for treating cancer, has raised $119M in a Series E funding round. The company said the new funding came from Hikma, a global pharmaceutical company, and Mizuho Bank and Dai-ichi Lif...

San Diego-based Blacksmith Medicines, a developer of biopharmaceuticals, says it has received $3.3M in funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Accordin...

Thousand Oaks-based Latigo Biotherapeutics, a biotherapeutics company developing non-opioid pain medications, says it has raised $135M in a Series A funding round. The funding was led by Westlake Village BioPartners, which originally incuba...

Carlsbad-based Tyra Biosciences ,a company developing precision medicines for targeting Fibroblast Growth Factor Receptor (FGFR) biology, has raised $200M in a private placement (PIPE). The publicly listed company said the funding was led b...

San Diego-based biotech developer Tr1X, a company developing therapies to treat autoimmune disease, announced this morning that it has raised $75M in a Series A financing round. The funding was led by The Column Group, and also included NEV...

San Diego-based Aspen Neuroscience, a biotechnology company which is developing treatments for Parkinson's disease, says it has named Ana Sousa, MSJ, as the company's Chief Regulatory Officer. Sousa has been the company's Senior Vice Presid...

Los Angeles-based EarlyDiagnostics announced this morning that it has appointed a new, Co-CEO to the company. According to the developer of cancer detection technology, it has appointed Gregory Critchfield as Co-CEO, effective January 1st. ...

San Diego-based Radionetics Oncology, a company that is working on cancer treatments, said this morning that it has raised $52.5M in a Series A funding. The funding was led by Frazier Life Sciences, 5AM Ventures and DCVC Bio. According to R...

Newport Beach-based private equity investor Windjammer Capital said this morning that it has acquired Bio X Cell, a producer of monoclonal antibodies (mAbs). Financial details of the deal were not announced. Windjammer said it acquired the ...

San Diego-based Kintara Therapeutics says it is reviewing "strategic alternatives", and has hired on a financial advisor. The biopharmaceuticals company said it will "review a range of strategic alternatives focused on maximizing stockholde...

Irvine-based Bright Uro, a company developing medical devices to treat lower urinary tract symptoms (LUTS), says it has raised $23M in a Series A financing. The funding was led by Laborie Medical Technologies, as well as others. The company...

San Diego-based Debut, which is applying synthetic biology to the fragrance industry, says it has raised $40M in a Series B funding round. The company said the funding was led by BOLD, the venture capital fund of L'Oreal. Debut says it is d...

Thousand Oaks-based Amgen has completed its acquisition of Horizons Therapeutics plc. in a deal worth $27.8 billion. According to Amgen, it paid $116.50 per share in cash for horizon Therapeutics. Horizon owns a number of treatments for rar...

San Diego-based pharmaceuticals company RayzeBio said on Tuesday that it has closed on its $358M IPO, selling 19,869,240 shares of its common stock at $18.00 per share. The IPO also saw an full exercise of additional shares sold by the unde...

Culver City-based immunotherapy developer ImmunityBio has received $470M in equity and debit financing from its founder, Dr. Patrick Soon-Shiong, the company said this morning. According to ImmunityBio, the new capitl includes exchange of $...

San Diego- and Boston-based Rapport Therapeutics has raised $150M in a Series B funding round, the company said this morning. According to the company, the funding was led by Cormorant Asset Management, and also included Fidelity Managemen...

Irvine-based Global Premier Fertility, a company which builds and manages fertility clinics, said it has received a new round of capital from its existing investors, along with a new, institutional funding partner. Size of the investment an...

Los Angeles-based Westlake Village BioPartners said this morning that it has raised a new, $450M fund, its third fund. According to the firm, the new fund brings its total raised to $1.3 billion. As part of the new fund, the firm said it ha...

Los Angeles-based Readout AI has raised a pre-seed funding round, which will help it "turbocharge the biostatistical and medical writing tasks associated with clinical trials." Size of the funding was not announced. According to the company...

San Diego-based Kate Therapeutics has raised $51M in a Series A funding round, the company announced this morning. The funding was co-led by Westlake Village BioPartners and Versant Ventures. According to the company, it is working on next ...

Los Angeles-based AHARA, a new startup focused on providing personalized nutrition suggestions, has raised $10.25M in a seed funding round. The funding was led by Greycroft, and also included Headline, SHAKTI, Sandy Sholl, Dr. Samuel Jampol...

Los Angeles-based Sensydia, a company working on non-invasive cardiac diagnostics, said this morning that it has received $3M in a NIH grant. According to the company, the funding came in the form of a Fast-Track Small Business grant from t...

San Diego-based Scientist.com, which operates what it calls a "preclinical research marketplace for the biopharma sector", says it has acquired a French company called Labs Explorer. According to the company, Labs explorer connects European...

San Diego-based biotechnology developer Zura Bio, a publicly traded biotech company focused on developing treatments for immune and inflammatory disorders, says it has received $80M in a financing. The company--which trades on the Nasdaq as...

San Diego-based Adcentrx Therapeutics, a biotech company which is focused on treatments for cancer and other diseases, has raised $38M in a Series A+ funding round. The company said the funding was led by Eight Roads Ventures, and also incl...

San Diego-based Epic Sciences has raise $24M in a Series G funding, the company said last week. According to the company, the funding was co-led by Deerfield Management and Arsenal Capital Partners, and also included Blue Ox Healthcare Part...